Shannon Thyme Klinger's Insider Trades & SAST Disclosures
Shannon Thyme Klinger's most recent trade in Moderna Inc was a trade of 1,139 Common Stock done . Disclosure was reported to the exchange on March 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Shannon Thyme Klinger.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 1,139 | 26,163 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 1,139 | 1,139 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.30 per share. | 07 Mar 2025 | 551 | 25,612 (0%) | 0% | 34.3 | 18,899 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 55,543 | 55,543 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 34,655 | 34,655 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 329 | 25,184 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 329 | 2,630 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 233 | 24,968 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 233 | 931 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.09 per share. | 28 Feb 2025 | 160 | 25,024 (0%) | 0% | 31.1 | 4,974 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.09 per share. | 28 Feb 2025 | 113 | 24,855 (0%) | 0% | 31.1 | 3,513 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 3,094 | 24,861 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 3,094 | 9,283 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 2,653 | 0 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 2,653 | 26,018 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.58 per share. | 27 Feb 2025 | 1,496 | 23,365 (0%) | 0% | 33.6 | 50,236 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.58 per share. | 27 Feb 2025 | 1,283 | 24,735 (0%) | 0% | 33.6 | 43,083 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 2,047 | 22,493 (0%) | 0% | 0 | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.93 per share. | 12 Feb 2025 | 1,068 | 21,425 (0%) | 0% | 30.9 | 33,033 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 1,138 | 2,278 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 1,138 | 20,975 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 44.68 per share. | 06 Dec 2024 | 529 | 20,446 (0%) | 0% | 44.7 | 23,637 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 188,761 | 188,761 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 232 | 1,164 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 232 | 19,949 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 43.29 per share. | 02 Dec 2024 | 112 | 19,837 (0%) | 0% | 43.3 | 4,849 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 2,652 | 2,653 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 2,652 | 21,135 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 42.79 per share. | 27 Nov 2024 | 1,418 | 19,717 (0%) | 0% | 42.8 | 60,675 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 329 | 18,483 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 329 | 2,959 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Sep 2024 | 1,139 | 3,416 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Sep 2024 | 1,139 | 18,705 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 73.57 per share. | 06 Sep 2024 | 551 | 18,154 (0%) | 0% | 73.6 | 40,539 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2024 | 233 | 1,396 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2024 | 233 | 17,680 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 76.99 per share. | 30 Aug 2024 | 114 | 17,566 (0%) | 0% | 77.0 | 8,777 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2024 | 329 | 3,288 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2024 | 329 | 17,609 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 78.02 per share. | 28 Aug 2024 | 162 | 17,447 (0%) | 0% | 78.0 | 12,640 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2024 | 2,652 | 5,305 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2024 | 2,652 | 18,599 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 79.39 per share. | 27 Aug 2024 | 1,319 | 17,280 (0%) | 0% | 79.4 | 104,722 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 9,108 | 21,125 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 9,108 | 0 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 148.09 per share. | 07 Jun 2024 | 5,178 | 15,947 (0%) | 0% | 148.1 | 766,785 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 1,139 | 4,555 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 1,139 | 12,017 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 232 | 1,629 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 232 | 11,000 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 140.72 per share. | 31 May 2024 | 122 | 10,878 (0%) | 0% | 140.7 | 17,168 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 328 | 3,617 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 328 | 10,951 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 144.50 per share. | 28 May 2024 | 183 | 10,768 (0%) | 0% | 144.5 | 26,444 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2024 | 2,652 | 11,919 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2024 | 2,652 | 7,957 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 162.47 per share. | 24 May 2024 | 1,296 | 10,623 (0%) | 0% | 162.5 | 210,566 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 1,138 | 9,811 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 1,138 | 5,694 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 99.05 per share. | 07 Mar 2024 | 544 | 9,267 (0%) | 0% | 99.1 | 53,884 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 233 | 1,861 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 233 | 8,790 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 94.34 per share. | 01 Mar 2024 | 117 | 8,673 (0%) | 0% | 94.3 | 11,038 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 1,315 | 9,227 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 1,315 | 3,945 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 94.57 per share. | 28 Feb 2024 | 670 | 8,557 (0%) | 0% | 94.6 | 63,363 | Common Stock |
| Moderna Inc | Shannon Klinger Thyme | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 60,216 | 60,216 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | Klinger Thyme Shannon | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 23,635 | 23,635 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | Klinger Thyme Shannon | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 12,377 | 12,377 | - | - | Restricted Stock Units | |
| Moderna Inc | Klinger Thyme Shannon | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 10,609 | 10,609 | - | - | Restricted Stock Units | |
| Moderna Inc | Thyme Klinger Shannon | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2023 | 1,139 | 6,832 | - | - | Restricted Stock Units | |
| Moderna Inc | Klinger Shannon Thyme | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2023 | 1,139 | 8,475 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Klinger Shannon Thyme | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 79.09 per share. | 07 Dec 2023 | 563 | 7,912 (0%) | 0% | 79.1 | 44,525 | Common Stock |
| Moderna Inc | Klinger Thyme Shannon | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 232 | 7,447 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 232 | 2,094 | - | - | Restricted Stock Units | |
| Moderna Inc | Thyme Klinger Shannon | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 79.32 per share. | 01 Dec 2023 | 111 | 7,336 (0%) | 0% | 79.3 | 8,804 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 1,139 | 9,109 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 1,139 | 7,081 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 124.09 per share. | 07 Jun 2023 | 565 | 6,516 (0%) | 0% | 124.1 | 70,111 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 232 | 2,559 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 232 | 6,052 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 130.33 per share. | 01 Jun 2023 | 110 | 5,942 (0%) | 0% | 130.3 | 14,336 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2023 | 1,138 | 10,248 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2023 | 1,138 | 6,381 (0%) | 0% | 0 | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 141.51 per share. | 07 Mar 2023 | 561 | 5,820 (0%) | 0% | 141.5 | 79,388 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 930 | 2,791 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 930 | 5,702 (0%) | 0% | 0 | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 136.43 per share. | 01 Mar 2023 | 459 | 5,243 (0%) | 0% | 136.4 | 62,623 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 20,040 | 20,040 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 5,260 | 5,260 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2022 | 1,139 | 11,386 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2022 | 1,139 | 5,262 (0%) | 0% | 0 | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 179.15 per share. | 07 Dec 2022 | 490 | 4,772 (0%) | 0% | 179.1 | 87,783 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2022 | 1,138 | 12,525 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2022 | 1,138 | 4,427 (0%) | 0% | 0 | Common Stock | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 137.44 per share. | 07 Sep 2022 | 478 | 3,949 (0%) | 0% | 137.4 | 65,698 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2022 | 4,554 | 13,663 | - | - | Restricted Stock Units | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 140.00 per share. | 07 Jun 2022 | 4,554 | 4,554 (0%) | 0% | 140 | 637,560 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 148.12 per share. | 07 Jun 2022 | 1,265 | 3,289 (0%) | 0% | 148.1 | 187,371 | Common Stock |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 15,091 | 15,091 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 3,721 | 3,721 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges